看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。- P! n$ x/ P/ r/ v. [- Y
7 D0 S1 B6 y- c: c+ j* }7 D+ @# W
Currently available feasibility data for possible combination strategies.
- _) N$ C' g) p+ _7 R: `/ U+ z3 b) M7 k————————————————————————————————' i9 A0 r; ]; W- \9 R
Combination Feasibility according to preliminary data
" `3 v' d% a {! X6 V5 R——————————————————————————————————
" I- B5 H1 V! n) ]% l3 ~, HBevacizumab + sorafenib Yes, reduced dose
$ K$ F+ k$ b+ B0 O4 J* Y% x- gBevacizumab + sunitinib† No 9 y4 ]) J$ I9 U! Y
Bevacizumab + temsirolimus Yes
8 s. \* L) r% z4 l+ _Bevacizumab + everolimus Yes
0 T8 S6 k* V+ X4 h- g g1 sSorafenib + sunitinib ? / y* t8 Z' d& |' |
Sorafenib + temsirolimus Yes, reduced dose
+ j6 l0 R, F. D7 Q. \) b2 h$ BSorafenib + everolimus Yes, reduced dose & M6 z# g1 r9 O$ q' z2 k) x
Sunitinib + temsirolimus† No
0 e) q/ J# D* |4 f2 r6 B hSunitinib + everolimus ?
( M7 V( X7 c" R0 ZTemsirolimus + everolimus ? / ?! ~. H/ {, B1 C
————————————————————* a0 D G# @" f3 R) _
†Led to US FDA warning.
$ }/ c4 y6 U6 ~7 i7 h?: As yet unattempted combination.
7 z& H% u4 t9 r2 E( X4 U |